- Home
- NSIT vs KRYS Comparison
NSIT vs KRYS Comparison
Compare NSIT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSIT
- KRYS
- Stock Information
- Founded
- NSIT 1988
- KRYS 2015
- Country
- NSIT United States
- KRYS United States
- Employees
- NSIT N/A
- KRYS N/A
- Industry
- NSIT EDP Services
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NSIT Technology
- KRYS Health Care
- Exchange
- NSIT Nasdaq
- KRYS Nasdaq
- Market Cap
- NSIT 4.7B
- KRYS 4.5B
- IPO Year
- NSIT 1995
- KRYS 2017
- Fundamental
- Price
- NSIT $157.51
- KRYS $152.92
- Analyst Decision
- NSIT Buy
- KRYS Strong Buy
- Analyst Count
- NSIT 4
- KRYS 7
- Target Price
- NSIT $212.50
- KRYS $206.67
- AVG Volume (30 Days)
- NSIT 378.1K
- KRYS 294.1K
- Earning Date
- NSIT 02-13-2025
- KRYS 02-24-2025
- Dividend Yield
- NSIT N/A
- KRYS N/A
- EPS Growth
- NSIT 9.36
- KRYS N/A
- EPS
- NSIT 7.93
- KRYS 1.77
- Revenue
- NSIT $8,865,044,000.00
- KRYS $241,519,000.00
- Revenue This Year
- NSIT N/A
- KRYS $485.65
- Revenue Next Year
- NSIT $4.19
- KRYS $58.64
- P/E Ratio
- NSIT $19.85
- KRYS $86.24
- Revenue Growth
- NSIT N/A
- KRYS 2722.80
- 52 Week Low
- NSIT $146.56
- KRYS $107.50
- 52 Week High
- NSIT $228.07
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- NSIT 50.59
- KRYS 35.90
- Support Level
- NSIT $152.01
- KRYS $155.48
- Resistance Level
- NSIT $155.13
- KRYS $161.71
- Average True Range (ATR)
- NSIT 4.63
- KRYS 5.34
- MACD
- NSIT 1.14
- KRYS -0.05
- Stochastic Oscillator
- NSIT 84.13
- KRYS 12.70
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.